Mechanisms of ligand binding and agonist efficacy at the human D2SHORT dopamine receptor

被引：0
|
作者：
Payne, SL [1 ]
Strange, PG [1 ]
机构：
[1] Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1998年 / 125卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
73P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Agonist action at D2(long) dopamine receptors:: ligand binding and functional assays
    Gardner, B
    Strange, PG
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (05) : 978 - 984
  • [22] AN ANTIBODY TO DOPAMINE-D2 RECEPTOR INHIBITS DOPAMINE ANTAGONIST AND AGONIST BINDING TO DOPAMINE-D2 RECEPTOR CDNA TRANSFECTED MOUSE FIBROBLAST CELLS
    FAROOQUI, SM
    PRASAD, C
    [J]. LIFE SCIENCES, 1992, 51 (19) : 1509 - 1516
  • [23] Inverse agonist profiling of antipsychotics at the human D2 dopamine receptor
    Burstein, ES
    Ma, J
    Wong, S
    Weiner, DM
    Brann, MR
    [J]. SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 509 - 509
  • [24] Impact of an Adenosine A2A Receptor Agonist and Antagonist on Binding of the Dopamine D2 Receptor Ligand [11C]raclopride in the Rodent Striatum
    Prasad, Kavya
    de Vries, Erik F. J.
    Sijbesma, Jurgen W. A.
    Garcia-Varela, Lara
    Vazquez-Matias, Daniel A.
    Moraga-Amaro, Rodrigo
    Willemsen, Antoon T. M.
    Dierckx, Rudi A. J. O.
    van Waarde, Aren
    [J]. MOLECULAR PHARMACEUTICS, 2022, 19 (08) : 2992 - 3001
  • [25] Schizophrenia thalamus imaging: Low benzamide binding to dopamine D2 receptors suggests fewer D2Short receptors and fewer presynaptic terminals
    Seeman, Philip
    [J]. PSYCHIATRY RESEARCH-NEUROIMAGING, 2013, 214 (03) : 175 - 180
  • [26] Dopamine D2 receptor dimer formation -: Evidence from ligand binding
    Armstrong, D
    Strange, PG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (25) : 22621 - 22629
  • [27] Impact of A2A R agonist and antagonist on binding of the dopamine D2 receptor ligand [11C]raclopride in the rodent striatum
    Prasad, K.
    de Vries, E. F. J.
    Sijbesma, J. W. A.
    Attia, K. A.
    Kwizera, C.
    Garcia-Varela, L.
    Vazquez-Matias, D. A.
    Moraga-Amaro, R.
    Vallez-Garcia, D.
    Willemsen, A. T.
    Dierckx, R. A. J. O.
    van Waarde, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S114 - S115
  • [28] DOPAMINE-D2 RECEPTOR-BINDING PROPERTIES OF [H-3] U-86170, A DOPAMINE RECEPTOR AGONIST
    LAHTI, RA
    EVANS, DL
    FIGUR, LM
    CARRIGAN, KJ
    MOON, MW
    HSI, RS
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 202 (02) : 289 - 291
  • [29] Co-operativity in agonist binding at the D2 dopamine receptor: evidence from agonist dissociation kinetics
    Kara, Elodie
    Lin, Hong
    Strange, Philip G.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2010, 112 (06) : 1442 - 1453
  • [30] Atypical kinetics for a series of putative dopamine antagonists to reverse the low-magnitude Ca2+ phase in the dopamine-bound D2short receptor state
    Pauwels, PJ
    Koek, W
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 (01) : 82 - 85
12345